US FDA greenlights Viridian's thyroid eye disease drug

▤ Summary

The US FDA has approved Viridian’s thyroid eye disease drug. This gives Viridian a major clinical and commercial milestone in its pharmaceutical pipeline. The news centers on drug development and regulatory clearance rather than software products or company operations. For software vendors, the event has limited immediate trigger value beyond broader life sciences workflow or compliance relevance.

▦ Linked Companies